Login / Signup

The association between low-level viraemia and subsequent viral non-suppression among people living with HIV/AIDS on antiretroviral therapy in Uganda.

Nicholus NanyeenyaLarry William ChangNoah KiwanukaEsther NasuunaDamalie NakanjakoGertrude NakigoziSimon Peter Sebina KibiraSusan NabaddaCharles KiyagaFredrick Makumbi
Published in: PloS one (2023)
Our study indicated that PLHIV with LLV increased from 2.0% in 2016 to 8.6% in 2020, and PLHIV with LLV had 4.1 times the hazard rate of developing viral non-suppression, as compared to PLHIV with a non-detectable VL. Hence the need to review the VL testing algorithm and also manage LLV in Uganda.
Keyphrases
  • hiv aids
  • antiretroviral therapy
  • hiv infected
  • human immunodeficiency virus
  • sars cov
  • hiv positive
  • hiv infected patients
  • machine learning
  • deep learning
  • south africa